Healthcare provider profile · identity verified

Yao Chen, MD

Internal Medicine · ROCHESTER, NY · NPI 1194246397

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	918	290
Amlodipine Besylate	Amlodipine Besylate	507	142
Lisinopril	Lisinopril	460	149
Levothyroxine Sodium	Levothyroxine Sodium	381	102
Gabapentin	Gabapentin	353	103
Losartan Potassium	Losartan Potassium	292	82
Omeprazole	Omeprazole	272	73
Pantoprazole Sodium	Pantoprazole Sodium	227	73
Metformin Hcl	Metformin Hcl	218	62
Hydrochlorothiazide	Hydrochlorothiazide	201	71
Metoprolol Succinate	Metoprolol Succinate	201	68
Albuterol Sulfate Hfa	Albuterol Sulfate	173	59
Metformin Hcl Er	Metformin Hcl	167	45
Tamsulosin Hcl	Tamsulosin Hcl	157	47
Trazodone Hcl	Trazodone Hcl	152	45
Furosemide	Furosemide	135	47
Fluticasone Propionate	Fluticasone Propionate	133	48
Famotidine	Famotidine	128	41
Pravastatin Sodium	Pravastatin Sodium	128	41
Simvastatin	Simvastatin	124	41
Metoprolol Tartrate	Metoprolol Tartrate	119	36
Rosuvastatin Calcium	Rosuvastatin Calcium	110	36
Ozempic	Semaglutide	104	27
Sertraline Hcl	Sertraline Hcl	89	32
Zolpidem Tartrate	Zolpidem Tartrate	87	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	80	17
Meloxicam	Meloxicam	80	22
Eliquis	Apixaban	79	30
Pregabalin	Pregabalin	77	13
Bupropion Xl	Bupropion Hcl	75	22
Alprazolam	Alprazolam	71	19
Citalopram Hbr	Citalopram Hydrobromide	71	22
Tramadol Hcl	Tramadol Hcl	63	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	61	suppressed
Atenolol	Atenolol	57	16
Chlorthalidone	Chlorthalidone	57	22
Venlafaxine Hcl Er	Venlafaxine Hcl	55	16
Duloxetine Hcl	Duloxetine Hcl	54	21
Warfarin Sodium	Warfarin Sodium	54	18
Clonazepam	Clonazepam	52	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	24
Allopurinol	Allopurinol	49	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	24
Fluoxetine Hcl	Fluoxetine Hcl	48	12
Glimepiride	Glimepiride	48	18
Celecoxib	Celecoxib	47	16
Montelukast Sodium	Montelukast Sodium	47	12
Oxycodone Hcl	Oxycodone Hcl	47	suppressed
Baclofen	Baclofen	45	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	45	16
Glipizide	Glipizide	44	13
Fentanyl	Fentanyl	43	suppressed
Tizanidine Hcl	Tizanidine Hcl	43	14
Alendronate Sodium	Alendronate Sodium	42	13
Terazosin Hcl	Terazosin Hcl	41	13
Torsemide	Torsemide	41	14
Mirtazapine	Mirtazapine	40	13
Spironolactone	Spironolactone	40	14
Ondansetron Hcl	Ondansetron Hcl	39	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	38	12
Carvedilol	Carvedilol	36	16
Clopidogrel	Clopidogrel Bisulfate	36	14
Lorazepam	Lorazepam	36	12
Morphine Sulfate Er	Morphine Sulfate	36	suppressed
Lovastatin	Lovastatin	35	13
Paroxetine Hcl	Paroxetine Hcl	35	11
Finasteride	Finasteride	34	12
Amoxicillin	Amoxicillin	33	17
Glipizide Er	Glipizide	33	12
Labetalol Hcl	Labetalol Hcl	33	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	12
Ezetimibe	Ezetimibe	31	12
Oxybutynin Chloride Er	Oxybutynin Chloride	31	suppressed
Synthroid	Levothyroxine Sodium	31	suppressed
Trulicity	Dulaglutide	30	suppressed
Ibuprofen	Ibuprofen	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Potassium Chloride	Potassium Chloride	28	13
Rybelsus	Semaglutide	28	11
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Enalapril Maleate	Enalapril Maleate	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Irbesartan	Irbesartan	25	suppressed
Jardiance	Empagliflozin	25	12
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Sucralfate	Sucralfate	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	20
Felodipine Er	Felodipine	24	suppressed
Azithromycin	Azithromycin	23	14
Diazepam	Diazepam	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Lansoprazole	Lansoprazole	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	suppressed
Prednisone	Prednisone	22	14
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Nystatin	Nystatin	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	19	suppressed
Morphine Sulfate	Morphine Sulfate	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Promethazine Hcl	Promethazine Hcl	18	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Naproxen	Naproxen	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Doxepin Hcl	Doxepin Hcl	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Topiramate	Topiramate	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Valsartan	Valsartan	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Arnuity Ellipta	Fluticasone Furoate	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	13
Oxycontin	Oxycodone Hcl	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	11
Loperamide	Loperamide Hcl	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Cephalexin	Cephalexin	13	12
Gemfibrozil	Gemfibrozil	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Ramipril	Ramipril	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	11	suppressed
Desonide	Desonide	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Etodolac	Etodolac	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Risperidone	Risperidone	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed
Vilazodone Hcl	Vilazodone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error